Does Dr. ROBERT ALEXANDER have financial conflicts of interest?

Dr. ROBERT ALEXANDER (PA-C) has received a total of $1,514 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,514 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBERT ALEXANDER?

According to CMS Open Payments data, Dr. ROBERT ALEXANDER received funding from E.R. SQUIBB & SONS, L.L.C ($444), ALNYLAM PHARMACEUTICALS ($402), and ABBOTT LABORATORIES ($334).

Does Dr. ROBERT ALEXANDER receive research grants or speaking fees?

Dr. ROBERT ALEXANDER has received $1,514 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ROBERT ALEXANDER

PA-CReal-Time Hydrated

Specialty: Physician Assistant, Medical

Practice Location: MALMSTROM AFB, MT 59402

NPI Number: 1073842977

LIFETIME INDUSTRY VALUE

$1,514

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALEXANDER is a verified Physician Assistant, Medical practitioner based in MALMSTROM AFB, MT.

Between 2021 and 2025, Dr. ALEXANDER had an overall industry promotional and research financial footprint of $1,514 as recorded in the federal CMS Open Payments database.

$1,514 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALEXANDER's primary funding source is E.R. SQUIBB & SONS, L.L.C, which accounts for $444 (representing 29.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

E.R. SQUIBB & SONS, L.L.C

Rank 1

$444

29.3%

ALNYLAM PHARMACEUTICALS

Rank 2

$402

26.6%

ABBOTT LABORATORIES

Rank 3

$334

22%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.